InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
33%
T+90 mean return
-4.2%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Mason Caren L, Chairman & CEO. Director active across 1 company, notably Staar Surgical Co. Aggregated, 7 disclosures have been logged. Activity tracked since 10 May 2021. The latest transaction was filed on 6 June 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
12,886 shares@ US$7.760.0082% mcap6.0% of flowCommon StockSEC:0001209191-22-034528:0
35,000 shares@ US$9.300.027% mcap19.8% of flowCommon StockSEC:0001209191-22-031137:0
20,269 shares0Common StockSEC:0001209191-22-017269:0
35,000 shares@ US$7.760.021% mcap41.1% of flowCommon StockSEC:0001209191-21-065651
35,000 shares@ US$7.760.021% mcap15.3% of flowCommon StockSEC:0001209191-21-065651:0
53,500 shares@ US$7.760.030% mcap21.8% of flowCommon StockSEC:0001209191-21-032113:0
53,500 shares@ US$7.7621.8% of flowCommon StockSEC:0001209191-21-032113
7 of 7 declarations
About Mason Caren L
Caren L. Mason is the President & CEO of STAAR SURGICAL CO. She is responsible for the strategic direction of the company and overseeing its operations. Caren L. Mason plays a key role in product development and enhancing the customer experience. Her expertise in healthcare services and business management is essential to ensure the growth and sustainability of STAAR SURGICAL CO.
